FBRX - NASDAQ

Forte Biosciences, Inc.

FBRX·NASDAQ

$16.69

-8.2%

HealthcareBiotechnology

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$231.75M

EPS-4.7100

P/E Ratio-3.54

Earnings Date08/13/2026

fbrx

Total Equity

Last Annual Value

60.99M

3-Year CAGR

16%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Forte Biosciences, Inc. Competitors Analysis of Total Equity

FBRX · NASDAQ

Company	Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Forte Biosciences, Inc. NASDAQ:FBRX	60.99M	20.0%	8.0%	24.2%
Nkarta, Inc. NASDAQ:NKTX	312.32M	4.6%	4.5%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	45.39M	-13.3%	-20.2%	8.7%
Seres Therapeutics, Inc. NASDAQ:MCRB	44.22M	N/A	-19.6%	-10.4%
Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP	245.15M	32.4%	2.3%	25.5%
Actuate Therapeutics Inc NASDAQ:ACTU	7.92M	N/A	N/A	N/A
Applied Therapeutics, Inc. NASDAQ:APLT	57.01M	N/A	-1.8%	N/A
Fate Therapeutics, Inc. NASDAQ:FATE	207.18M	-17.5%	-21.1%	11.0%
PepGen Inc. NASDAQ:PEPG	147.44M	10.8%	2.1%	N/A
Alector, Inc. NASDAQ:ALEC	30.65M	-38.9%	-36.7%	N/A
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	147.50M	N/A	16.4%	32.4%

Forte Biosciences, Inc. Fair Value Envelope

FBRX · NASDAQ

Our analysis suggests that FBRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $16.69, this represents a potential HIDDEN relative to our calculated worth for Forte Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $16.69

Related Guides

Blog Categories

Continue your FBRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.